Novel human cancer cell-line genomic model using CRISPR/Cas9 for assessing methotrexate pharmacogenomics: MiSSK study - Phase I

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)105-106
Number of pages2
JournalAsia-Pacific Journal of Clinical Oncology
Volume15
Publication statusPublished - Nov 2019

Cite this